Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Manchester, GBR
PO Box 1, Lankro Way, Eccles
Manchester, M30 0BH, GBR


Chief Executive Officer
Chief Operating Officer
Board of Directors
Executive Director
Chief Scientific and Development Officer
Executive Chairman
Non Executive Director
Non Executive Director
Show All People




F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.

Recent Milestones

  • Dollar
    F2G received $30M in Venture Round funding. (9/5/12)
    Posted 9/5/12 at 9:11pm via
  • Dollar
    F2G received $11.8M (£6.3M) in Venture Round funding. (8/18/08)
    Posted 6/22/09 at 11:37pm via
  • Check
    F2G added Shane Kelly as Chief Executive Officer.
    Posted 6/22/09 at 11:25pm



F2G screenshot
Above: F2G
Uploaded: 6/23/09


  1. F2G Ltd completes £6.3million financing round to fund pre-clinical and clinical development ( [edit]
  2. F2G Ltd Completes $30 Million Financing Round to Fund Pre-clinical and Clinical Development of Novel Anti-fungal Compounds ( [edit]
Edit This Page
Last Edited 12/14/13

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy